A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier.

Building on the success of the Oncotype DX Breast Recurrence Score^® Test and the Cologuard^® stool DNA-based colorectal cancer screening test¹ , Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.

We serve patients in more than 90 countries and our Oncotype DX^® test is the most commonly used genomic assay in the NHS for adjuvant chemotherapy treatment decision-making.

^{1.  This product is only available in the US}